Stem cell mobilization is life saving in an animal model of acute liver failure

Annals of Surgery

Volumn 252, Issue 4, 2010, Pages 591-595

  Mark, Anthony L ^a   Sun, Zhaoli ^b   Warren, Daniel S ^b   Lonze, Bonnie E ^b   Knabel, Matthew K ^b   Williams, George M Melville ^b   Locke, Jayme E ^b   Montgomery, Robert A ^b   Cameron, Andrew M ^b  

^a USUHS/Walter Reed Army Hospital   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR; CARBON TETRACHLORIDE; CD34 ANTIGEN; HETEROCYCLIC COMPOUND;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJURY SCALE; LIVER FAILURE; LIVER PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL MOBILIZATION; SURVIVAL; ANIMAL; BLOOD; CHEMICALLY INDUCED; FLOW CYTOMETRY; IMMUNOLOGY; LEWIS RAT; LIVER; LIVER FAILURE, ACUTE; MOUSE; PATHOLOGY; PROCEDURES;

ANIMALS; ANTIGENS, CD34; CARBON TETRACHLORIDE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FAILURE, ACUTE; MICE; RATS; RATS, INBRED LEW; TRANSAMINASES;

EID: 77957999594     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181f4e479     Document Type: Article

References (22)

1. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542-553.
2. Lee WM, Squires RH, Nyberg SL, et al. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401-1415.
3. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276: 60-66.
4. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168-1170.
5. Simmons DL, Satterthwaite AB, Tenen DG, et al. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J. Immunol. 1992;148:267-271.
6. De Silvestro G, Vicarioto M, Donadel C, et al. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogas-troenterology. 2004;51:805-810.
7. Di Campli C, Piscaglia AC, Giulante F, et al. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc. 2005;37:2563-2566.
8. Hahn T, Wingard JR, Anderson KC, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidenced-based review. Biol Blood Marrow Transplant. 2003;9:4-37.
9. Flomenberg N, Devine SM, Dipersio JF, et al. The use of AMD3100 and G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005;106:1867-1874.
10. Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006;34:967-975.
11. Mozobil (Plerixafor Injection) [product monograph]. Cambridge, MA: Gen-zyme Corporation; 2009.
12. Farmer DG, Anselmo DM, Ghobrial RM, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666-675.
13. Gaia S, Smedile A, Omede P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol. 2006;45:13-19.
14. Lorenzini S, Isidori A, Catani L, et al. Stem cell mobilization and collection in patients with liver cirrhosis. Ailment Pharmacol Ther. 2008;27:932-939.
15. Di Campli C, Zocco MA, Saulinier N, et al. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis. 2007;39:1071-1076.
16. Okumoto K, Saito T, Onodera M, et al. Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis. J Gastroenterol Hepatol. 2007;22:1265-1270.
17. Liu F, Liu ZD, Wu N, et al. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl. 2009;15:1092-1100.
18. Uy GL, Rettig MP, Cashen AF. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther. 2008;8: 1797-1804.
19. Sun Z, Zhang X, Locke JE, et al. Recruitment of host progenitor cells in rat liver transplants. Hepatology. 2009;49:587-597.
20. Ince H, Petzsch M, Dieter Kleine H, et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction. Circulation. 2005;112:I73-I80.
21. Leone AM, Rutella S, Bonanno G, et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol. 2006;111:202-208.
22. Stokman G, Leemans JC, Claessen N, et al. Hematopoietic stem cell mobi lization therapy accelerates recovery of renal function independent of stem cell contribution. J Am Soc Nephrol. 2005;16:1684-1692.